THE THREE-YEAR EFFECT OF BIPHOSPHONATES ON BONE MINERAL DENSITY AFTER DENOSUMAB WITHDRAWAL: OBSERVATIONS FROM A REAL-WORLD STUDY

被引：0
|
作者：
Farias, V. [1 ]
Morejon Barragan, A. [2 ]
Pereyra, A. [2 ]
Jerkovich, F. [3 ]
Gonzalez Pernas, M. [3 ]
Abdala, R. [3 ]
Longobardi, V. [4 ]
Zanchetta, M. B. [4 ]
机构：
[1] Univ Salvador, IDIM, Buenos Aires, DF, Argentina
[2] Univ Salvador Usal, Buenos Aires, DF, Argentina
[3] Inst Invest Metabol IDIM, Buenos Aires, DF, Argentina
[4] Univ Salvador Usal, IDIM, Buenos Aires, DF, Argentina
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2023年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P794
引用
收藏
页码：S405 / S406
页数：2
相关论文
共 50 条
  • [41] Effect of Denosumab Three Years Therapy in Women with Osteoporosis and Contraindications to Oral Bisphosphonates on Bone Mineral Density
    Sawicki, Andrzej
    Janiak, Radoslaw
    Nawrot, Ireneusz
    Sawicki, Piotr
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S325 - S325
  • [42] Early administration of romosozumab prevents rebound of bone resorption related to denosumab withdrawal in fractured post-menopausal women: a real-world prospective study
    Piasentier, Alberto
    Fanti, Alessandro
    Birtolo, Maria Francesca
    Vena, Walter
    Colle, Roberto
    Gentile, Lucrezia Maria Silvana
    Jaafar, Simona
    Bossi, Antonio Carlo
    Lania, Andrea G.
    Mazziotti, Gherardo
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2025,
  • [43] Bone disease after liver transplantation (LT).: A three-year prospective study
    Monegal, A
    Navasa, M
    Guañabens, N
    Peris, P
    Pons, F
    de Osaba, JMM
    Ordi, J
    Rodes, J
    Muñoz-Gómez, J
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S142 - S142
  • [44] Three-year study of intermittent-cyclic etidronate treatment of women with low bone mineral
    Stanisic, M
    Pilipovic, N
    Radunovic, G
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 512 - 513
  • [45] Bone mineral density change over three years before, during and after switching to Romosozumab followed by Denosumab
    Kishikawa, Yoichi
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 181 - 181
  • [46] Fracture incidence after denosumab discontinuation: Real-world data from a large healthcare provider
    Tripto-Shkolnik, Liana
    Fund, Naama
    Rouach, Vanessa
    Chodick, Gabriel
    Shalev, Varda
    Goldshtein, Inbal
    BONE, 2020, 130
  • [47] FRACTURE INCIDENCE AFTER DENOSUMAB DISCONTINUATION: REAL-WORLD DATA FROM A LARGE HEALTHCARE PROVIDER
    Tripto-Shkolnik, L.
    Fund, N.
    Rouach, V.
    Chodick, G.
    Shalev, V.
    Goldshtein, I.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S168 - S169
  • [48] Effect of Three-year Multi-Component Exercise Training on Bone Mineral Density and Content in a Postmenopausal Woman with Osteoporosis: A Case Report
    Movaseghi, Farzaneh
    Sadeghi, Heydar
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2015, 44 (05) : 701 - 704
  • [49] Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: A three-year study
    Popp, Albrecht W.
    Guler, Sabina
    Lamy, Olivier
    Senn, Christoph
    Buffat, Helene
    Perrelet, Romain
    Hans, Didier
    Lippuner, Kurt
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (03) : 449 - 454
  • [50] Effect of denosumab treatment on bone mineral density and bone turnover markers in osteoporotic patients: real-life experience 2-year follow-up
    Yazan, Ceyda Dincer
    Bugdayci, Onur
    Ilgin, Can
    Yavuz, Dilek Gogas
    ARCHIVES OF OSTEOPOROSIS, 2022, 17 (01)
12345